Biodexa Pharmaceuticals (BDRX) Non-Current Debt (2013 - 2024)
Biodexa Pharmaceuticals (BDRX) posted Non-Current Debt of $151,453 for the quarter ended Dec 31, 2024, down 58.6% from $366,140 a year earlier.
Biodexa Pharmaceuticals (BDRX) Non-Current Debt (2013 - 2024) Analysis & Trends
As of Dec 31, 2024, Biodexa Pharmaceuticals' Non-Current Debt came in at $150,836, down 58.9% from the prior year.
- Annual Non-Current Debt has declined for three consecutive years, with a five-year compound annual growth rate of -53.9% (years ended Dec 2019 to Dec 2024).
- In prior years, Biodexa Pharmaceuticals' Non-Current Debt was $366,928 in the year ended Dec 31, 2023 (-36.0%), $573,013 in the year ended Dec 31, 2022 (-32.8%), $853,045 in the year ended Dec 31, 2021 and $77,049 in the year ended Dec 31, 2020 (-98.9%).
- The figure for the quarter ended Dec 31, 2024 stands as the lowest quarterly Non-Current Debt since the quarter ended Dec 31, 2020.
- The strongest year-over-year quarter for Non-Current Debt in the past five years was the quarter ended Dec 31, 2021, with growth of 954.9%; the weakest was the quarter ended Dec 31, 2020, with a decline of 98.9%.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Non-Current Debt (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,136.97 Bn | 1,105.55 Bn | 19.71 Bn | 47.86 Bn |
| 2 | Johnson & Johnson | 619.72 Bn | 538.25 Bn | 17.26 Bn | 37.34 Bn |
| 3 | AbbVie | 503.40 Bn | 476.52 Bn | 12.70 Bn | 62.48 Bn |
| 4 | Merck | 370.15 Bn | 324.53 Bn | 12.21 Bn | 51.08 Bn |
| 5 | Novartis Ag | 298.64 Bn | 262.63 Bn | 11.24 Bn | 1.96 Bn |
| 6 | Astrazeneca | 261.07 Bn | 234.76 Bn | 12.86 Bn | 23.68 Bn |
| 7 | Amgen | 237.00 Bn | 192.40 Bn | 7.24 Bn | 51.86 Bn |
| 8 | Gilead Sciences | 191.24 Bn | 165.43 Bn | 6.22 Bn | 23.83 Bn |
| 9 | Pfizer | 170.31 Bn | 116.96 Bn | 10.94 Bn | 60.50 Bn |
| 10 | Biodexa Pharmaceuticals | 4,123.69 | -23.40 Mn | - | - |
Historic Data
| Date | Value |
|---|---|
| Dec 31, 2024 | 148,079.37 |
| Jun 30, 2024 | 263,031.43 |
| Dec 31, 2023 | 375,652.60 |
| Jun 30, 2023 | 479,356.18 |
| Dec 31, 2022 | 558,207.93 |
| Dec 31, 2021 | 836,899.13 |
| Jun 30, 2021 | 944,075.28 |
| Dec 31, 2020 | 81,783.98 |
| Jun 30, 2020 | 131,723.12 |
| Dec 31, 2019 | 7.44 Mn |
| Jun 30, 2019 | 485,547.67 |
| Dec 31, 2018 | 1.12 Mn |
| Jun 30, 2018 | 8.05 Mn |
| Dec 31, 2017 | 8.31 Mn |
| Jun 30, 2017 | 1.59 Mn |
| Dec 31, 2016 | 1.99 Mn |
| Jun 30, 2016 | 1.94 Mn |
| Dec 31, 2015 | 2.23 Mn |
| Dec 31, 2014 | 2.32 Mn |
| Dec 31, 2013 | 3.50 Mn |
Biodexa Pharmaceuticals Non-Current Debt API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=non-current-debt&ticker=BDRX&period=max&api_key=YOUR_API_KEY
import requests
url = "https://data.businessquant.com/historic"
params = {"slug": "non-current-debt", "ticker": "BDRX", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()
const res = await fetch("https://data.businessquant.com/historic?slug=non-current-debt&ticker=BDRX&period=max&api_key=YOUR_API_KEY");
const data = await res.json();